Global Foot-and-Mouth Disease Research Update and Gap Analysis: 6 – Immunology

Transboundary and Emerging Diseases

Volumn 63, Issue , 2016, Pages 56-62

  Robinson, L ^a   Knight Jones, T J D ^b   Charleston, B ^c   Rodriguez, L L ^d   Gay, C G ^e   Sumption, K J ^f   Vosloo, W ^g  

^a Insight Editing London   (United Kingdom)

^b International Livestock Research Institute (ILRI)   (Zambia)

^c INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^d PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^e AGRICULTURAL RESEARCH SERVICE   (United States)

^f FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS   (Italy)

^g CSIRO   (Australia)

Author keywords

foot and mouth disease; immunity; immunology

Indexed keywords

ANIMAL; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IMMUNOLOGY;

ANIMALS; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS;

EID: 84975764224     PISSN: 18651674     EISSN: 18651682     Source Type: Journal    
DOI: 10.1111/tbed.12518     Document Type: Article

References (29)

1. Bucafusco, D., S. Di Giacomo, J. Pega, M. S. Juncos, J. M. Schammas, M. Perez-Filgueira, and A. V. Capozzo, 2014: Influence of antibodies transferred by colostrum in the immune responses of calves to current foot-and-mouth disease vaccines. Vaccine 32, 6576–6582.
2. Carr, B. V., E. A. Lefevre, M. A. Windsor, C. Inghese, S. Gubbins, H. Prentice, N. D. Juleff, and B. Charleston, 2013: CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle. J. Gen. Virol. 94, 97–107.
3. Cubillos-Zapata, C., E. Guzman, A. Turner, S. C. Gilbert, H. Prentice, J. C. Hope, and B. Charleston, 2011: Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo. J. Virol. 85, 9385–9394.
4. Dekker, A., P. Eble, N. Stockhofe, and G. Chenard, 2014: Intratypic heterologous vaccination of calves can induce an antibody response in presence of maternal antibodies against foot-and-mouth disease virus. BMC Vet. Res. 10, 127.
5. GFRA, 2010: Foot-and-mouth disease gap analysis (workshop report). Available at http://www.ars.usda.gov/GFRA/reports/NVS-FMD%20Gap%20Analysis%20Workshop%20Report%20December%202010.pdf (accessed March 07, 2016).
6. Grubman, M. J., 2010: Adenovirus serotype 5-vectored foot-and-mouth disease subunit vaccines: the first decade. Future Virol. 5, 51–64.
7. Guzman, E., J. Hope, G. Taylor, A. L. Smith, C. Cubillos-Zapata, and B. Charleston, 2014: Bovine gammadelta T cells are a major regulatory T cell subset. J. Immunol., 193, 208–222.
8. Habiela, M., J. Seago, E. Perez-Martin, R. Waters, M. Windsor, F. J. Salguero, J. Wood, B. Charleston, and N. Juleff, 2014: Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity. J. Gen. Virol. 95, 2329–2345.
9. Juleff, N., M. Windsor, E. A. Lefevre, S. Gubbins, P. Hamblin, E. Reid, K. McLaughlin, P. C. Beverley, I. W. Morrison, and B. Charleston, 2009: Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naive cattle. J. Virol. 83, 3626–3636.
10. Kaser, T., W. Gerner, and A. Saalmuller, 2011: Porcine regulatory T cells: mechanisms and T-cell targets of suppression. Dev. Comp. Immunol. 35, 1166–1172.
11. Langellotti, C., V. Quattrocchi, C. Alvarez, M. Ostrowski, V. Gnazzo, P. Zamorano, and M. Vermeulen, 2012: Foot-and-mouth disease virus causes a decrease in spleen dendritic cells and the early release of IFN-alpha in the plasma of mice. Differences between infectious and inactivated virus. Antiviral Res. 94, 62–71.
12. Langellotti, C., G. Cesar, I. Soria, V. Quattrocchi, C. Jancic, P. Zamorano, and M. Vermeulen, 2015: Foot-and-mouth disease virus infection of dendritic cells triggers phosphorylation of ERK1/2 inducing class I presentation and apoptosis. Vaccine 33, 4945–4953.
13. Lannes, N., S. Python, and A. Summerfield, 2012: Interplay of foot-and-mouth disease virus, antibodies and plasmacytoid dendritic cells: virus opsonization under non-neutralizing conditions results in enhanced interferon-alpha responses. Vet. Res. 43, 64.
14. Lavoria, M. A., S. Di-Giacomo, D. Bucafusco, O. L. Franco-Mahecha, D. M. Perez-Filgueira, and A. V. Capozzo, 2012: Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against Foot-and-Mouth Disease Virus in cattle. Vaccine 30, 6845–6850.
15. Montiel, N. A., G. Smoliga, and J. Arzt, 2013: Time-dependent biodistribution and transgene expression of a recombinant human adenovirus serotype 5-luciferase vector as a surrogate for rAd5-FMDV vaccines in cattle. Vet. Immunol. Immunopathol. 151, 37–48.
16. Oh, Y., L. Fleming, B. Statham, P. Hamblin, P. Barnett, D. J. Paton, J. H. Park, Y. S. Joo, and S. Parida, 2012: Interferon-gamma induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection. PLoS ONE 7, e44365.
17. Pandya, M., M. Rasmussen, A. Hansen, M. Nielsen, S. Buus, W. Golde, and J. Barlow, 2015: A modern approach for epitope prediction: identification of foot-and-mouth disease virus peptides binding bovine leukocyte antigen (BoLA) class I molecules. Immunogenetics 67, 691–703.
18. Patch, J. R., M. Kenney, J. M. Pacheco, M. J. Grubman, and W. T. Golde, 2013: Characterization of cytotoxic T lymphocyte function after foot-and-mouth disease virus infection and vaccination. Viral Immunol. 26, 239–249.
19. Patil, P. K., C. M. Sajjanar, C. Natarajan, and J. Bayry, 2014: Neutralizing antibody responses to foot-and-mouth disease quadrivalent (type O, A, C and Asia 1) vaccines in growing calves with pre-existing maternal antibodies. Vet. Microbiol. 169, 233–235.
20. Pedersen, L. E., M. Harndahl, M. Nielsen, J. R. Patch, G. Jungersen, S. Buus, and W. T. Golde, 2013: Identification of peptides from foot-and-mouth disease virus structural proteins bound by class I swine leukocyte antigen (SLA) alleles, SLA-1*0401 and SLA-2*0401. Anim. Genet. 44, 251–258.
21. Pega, J., D. Bucafusco, S. Di Giacomo, J. M. Schammas, D. Malacari, A. V. Capozzo, J. Arzt, C. Perez-Beascoechea, E. Maradei, L. L. Rodriguez, M. V. Borca, and M. Perez-Filgueira, 2013: Early adaptive immune responses in the respiratory tract of foot-and-mouth disease virus-infected cattle. J. Virol. 87, 2489–2495.
22. Pega, J., S. Di Giacomo, D. Bucafusco, J. M. Schammas, D. Malacari, F. Barrionuevo, A. V. Capozzo, L. L. Rodriguez, M. V. Borca, and M. Perez-Filgueira, 2015: Systemic foot-and-mouth disease vaccination in cattle promotes specific antibody-secreting cells at the respiratory tract and triggers local anamnestic responses upon aerosol infection. J. Virol. 89, 9581–9590.
23. Ramanathan, P., J. J. Zhu, E. A. Bishop, M. C. Puckette, E. Hartwig, M. J. Grubman, and L. L. Rodriguez, 2015: A colorimetric bioassay for high-throughput and cost-effectively assessing anti-foot-and-mouth disease virus activity. Vet. Immunol. Immunopathol. 164, 74–78.
24. Robinson, L., M. Windsor, K. McLaughlin, J. Hope, T. Jackson, and B. Charleston, 2011: Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells. J. Virol. 85, 2212–2223.
25. Summerfield, A., M. Alves, N. Ruggli, M. G. de Bruin, and K. C. McCullough, 2006: High IFN-alpha responses associated with depletion of lymphocytes and natural IFN-producing cells during classical swine fever. J. Interferon Cytokine Res. 26, 248–255.
26. US Department of Homeland Security, 2012: “New foot-and-mouth disease vaccine gets licensed for use on cattle”, Available at: www.dhs.gov/publication/st-piadc-press-release-oct-2012 (accessed October 30, 2015).
27. Wang, F., D. C. Ekiert, I. Ahmad, W. Yu, Y. Zhang, O. Bazirgan, A. Torkamani, T. Raudsepp, W. Mwangi, M. F. Criscitiello, I. A. Wilson, P. G. Schultz, and V. V. Smider, 2013: Reshaping antibody diversity. Cell 153, 1379–1393.
28. Wesley, R. D., and K. M. Lager, 2006: Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus. Vet. Microbiol. 118, 67–75.
29. Windsor, M. A., B. V. Carr, B. Bankowski, D. Gibson, E. Reid, P. Hamblin, S. Gubbins, N. Juleff, and B. Charleston, 2011: Cattle remain immunocompetent during the acute phase of foot-and-mouth disease virus infection. Vet. Res. 42, 108.